The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
$ 15.99 · 4.7 (309) · In stock
Utility of needle biopsy in centrally located lung cancer for
Recombinant Anti-LTK antibody [EPR5175(2)] (ab129155)
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
Identification of Ultrasound-Sensitive Prognostic Markers of LAML
Identification of Ultrasound-Sensitive Prognostic Markers of LAML
Biomolecules, Free Full-Text
Clinical application of the AMOY 9-in-1 panel to lung cancer
Review: biological implications of oncogenic rearrangements in non
Combinatorial tumor suppressor inactivation efficiently initiates
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung
Division of Cancer Immunology